APA (7th ed.) Citation

Wang Fang, Ye Yanfen, Xu Xia, Zhou Xuehui, Wang Jinhua, & Chen Xiaoxiang. (2013). CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery. BMC.

Chicago Style (17th ed.) Citation

Wang Fang, Ye Yanfen, Xu Xia, Zhou Xuehui, Wang Jinhua, and Chen Xiaoxiang. CA-125-indicated Asymptomatic Relapse Confers Survival Benefit to Ovarian Cancer Patients Who Underwent Secondary Cytoreduction Surgery. BMC, 2013.

MLA (9th ed.) Citation

Wang Fang, et al. CA-125-indicated Asymptomatic Relapse Confers Survival Benefit to Ovarian Cancer Patients Who Underwent Secondary Cytoreduction Surgery. BMC, 2013.